| Registered number |
| Registered number: | |||||||
| Balance Sheet | |||||||
| as at |
|||||||
| Notes | 2024 | 2023 | |||||
| £ | £ | ||||||
| Fixed assets | |||||||
| Investments | 3 | ||||||
| Current assets | |||||||
| Cash at bank and in hand | |||||||
| Creditors: amounts falling due within one year | 4 | ( |
( |
||||
| Net current assets | |||||||
| Net assets | |||||||
| Capital and reserves | |||||||
| Called up share capital | |||||||
| Profit and loss account | ( |
( |
|||||
| Shareholders' funds | |||||||
| KH Cromar | |||||||
| Director | |||||||
| Approved by the board on |
|||||||
| Notes to the Accounts | ||||||||
| for the year ended |
||||||||
| 1 | Accounting policies | |||||||
| Basis of preparation | ||||||||
| Exemption from preparing consolidated financial statements | ||||||||
| The company, and the group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and group are considered eligible for the exemption to prepare consolidated accounts. | ||||||||
| Going concern | ||||||||
| The company has a positive reserves position and thus the Board of Directors is satisfied that there are sufficient resources in place to continue operating for the foreseeable future. Thus the Directors have adopted the going concern basis of accounting in preparing the financial statements. | ||||||||
| Investments | ||||||||
| Debtors | ||||||||
| Cash and cash equivalents | ||||||||
| Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. | ||||||||
| Creditors | ||||||||
| Financial instruments | ||||||||
| The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other debtors and creditors, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Comprehensive Income. |
||||||||
| Share capital | ||||||||
| Ordinary shares are classified as equity. Called up share capital represents the nominal value of shares that have been issued. | ||||||||
| 2 | Employees | 2024 | 2023 | |||||
| Number | Number | |||||||
| Average number of persons employed by the company | ||||||||
| 3 | Investments | |||||||
| Investments in | ||||||||
| subsidiary | ||||||||
| undertakings | ||||||||
| £ | ||||||||
| Cost | ||||||||
| At 1 January 2024 | ||||||||
| Impairment | ( |
|||||||
| At 31 December 2024 | ||||||||
| Historical cost | ||||||||
| At 1 January 2024 | 4,500,000 | |||||||
| At 31 December 2024 | 4,500,000 | |||||||
Kilrevin Holdings Ltd is a wholly owned subsidiary undertaking of the company specialising in the wholesale supply of industrial consumables and packaging materials. The registered office of this company is at 127 Elliot Street, Glasgow G3 8EX. At 31 December 2024 the directors are of the opinion that the holding value of the company's investment in Kilrevin Holdings Ltd is impaired to the extent of £413. Consequently an impairment charge of £413 has been taken to the profit and loss account in the year thereby reducing the carrying value of the investment to £1,163,569. This reflects the net asset value of Kilrevin Holdings Ltd at 31 December 2024. |
||||||||
| 4 | Creditors: amounts falling due within one year | 2024 | 2023 | |||||
| £ | £ | |||||||
| Amounts owed to related parties | ||||||||
| 5 | Related party transactions | |||||||
During the years ended 31 December 2024 and 31 December 2023 there were no related party transactions. |
||||||||
| 6 | Controlling party | |||||||
| 7 | Other information | |||||||
| Errol & Co Ltd is a private company limited by shares and incorporated in Scotland. Its registered office is: | ||||||||
| 127-137 Elliot Street | ||||||||
| Glasgow | ||||||||
| Scotland | ||||||||
| G3 8EX | ||||||||